肝硬化对口服普萘洛尔后未结合型稳态血药浓度的影响。 - Suppr

Suppr

超能文献

The influence of cirrhosis on steady-state blood concentrations of unbound propranolol after oral administration.

作者信息

Wood A J, Kornhauser D M, Wilkinson G R, Shand D G, Branch R A

出版信息

Clin Pharmacokinet. 1978 Nov-Dec;3(6):478-87. doi: 10.2165/00003088-197803060-00005.

DOI:10.2165/00003088-197803060-00005

PMID:719984

Abstract

摘要

相似文献

The influence of cirrhosis on steady-state blood concentrations of unbound propranolol after oral administration.肝硬化对口服普萘洛尔后未结合型稳态血药浓度的影响。

Clin Pharmacokinet. 1978 Nov-Dec;3(6):478-87. doi: 10.2165/00003088-197803060-00005.

Enhanced plasma binding of propranolol and oxprenolol and induction of hexobarbital and antipyrine metabolism by rifampicin treatment in the dog.

Arch Int Pharmacodyn Ther. 1982 Oct;259(2):303-4.

Propranolol disposition in chronic liver disease: a physiological approach.慢性肝病中普萘洛尔的处置：一种生理学方法。

Clin Pharmacokinet. 1976;1(4):264-79. doi: 10.2165/00003088-197601040-00002.

Disposition of propranolol. VI. Independent variation in steady-state circulating drug concentrations and half-life as a result of plasma drug binding in man.普萘洛尔的处置。VI. 人体中血浆药物结合导致稳态循环药物浓度和半衰期的独立变化。

Clin Pharmacol Ther. 1973 Jul-Aug;14(4):494-500. doi: 10.1002/cpt1973144part1494.

Effects of feeding on the systemic clearance of indocyanine green and propranolol blood concentrations and plasma binding.进食对吲哚菁绿的全身清除率、普萘洛尔血药浓度及血浆蛋白结合率的影响。

Br J Clin Pharmacol. 1983 Mar;15(3):383-5. doi: 10.1111/j.1365-2125.1983.tb01516.x.

Effect of thyrotoxicosis on liver blood flow and propranolol disposition after long-term dosing.长期给药后甲状腺毒症对肝血流量和普萘洛尔处置的影响。

Clin Pharmacol Ther. 1983 May;33(5):603-8. doi: 10.1038/clpt.1983.81.

A study of the relationship between serum bile acids and propranolol pharmacokinetics and pharmacodynamics in patients with liver cirrhosis and in healthy controls.肝硬化患者与健康对照者血清胆汁酸与普萘洛尔药代动力学和药效学关系的研究

PLoS One. 2014 Jun 6;9(6):e97885. doi: 10.1371/journal.pone.0097885. eCollection 2014.

Effect of acute and chronic propranolol administration on antipyrine and paracetamol clearance in patients with chronic liver disease.急性和慢性给予普萘洛尔对慢性肝病患者安替比林和对乙酰氨基酚清除率的影响。

Am J Gastroenterol. 1989 Jul;84(7):723-6.

Proceedings: The influence of chronic liver disease on the elimination of d-propranolol, anti-pyrine, and indocyanine green.研究报告：慢性肝病对d-普萘洛尔、安替比林和吲哚菁绿消除的影响

Gut. 1974 Oct;15(10):837-8.

Disposition of propranolol. V. Drug accumulation and steady-state concentrations during chronic oral administration in man.普萘洛尔的处置。V. 人体长期口服给药期间的药物蓄积和稳态浓度。

Clin Pharmacol Ther. 1973 Jul-Aug;14(4):487-93. doi: 10.1002/cpt1973144part1487.

引用本文的文献

Understanding drug-drug interaction and pharmacogenomic changes in pharmacokinetics for metabolized drugs.了解代谢药物的药代动力学中的药物-药物相互作用和药物基因组学变化。

J Pharmacokinet Pharmacodyn. 2019 Apr;46(2):155-163. doi: 10.1007/s10928-019-09626-7. Epub 2019 Mar 25.

A Prediction Model of Drug Exposure in Cirrhotic Patients According to Child-Pugh Classification.基于Child-Pugh分类的肝硬化患者药物暴露预测模型

Clin Pharmacokinet. 2015 Dec;54(12):1245-58. doi: 10.1007/s40262-015-0288-9.

Pharmacokinetics and pharmacodynamics of cinacalcet in hepatic impairment : phase I, open-label, parallel-group, single-dose, single-centre study.西那卡塞在肝损伤中的药代动力学和药效学：I期、开放标签、平行组、单剂量、单中心研究。

Clin Drug Investig. 2008;28(10):635-43. doi: 10.2165/00044011-200828100-00004.

Time-dependent modifications of splanchnic circulation in female pigs submitted to end-to-side portacaval anastomosis.接受端侧门腔静脉吻合术的雌性猪内脏循环的时间依赖性改变。

Dig Dis Sci. 2001 Mar;46(3):489-94. doi: 10.1023/a:1005678627599.

Drug administration in chronic liver disease.慢性肝病中的药物给药

Drug Saf. 1997 Jul;17(1):47-73. doi: 10.2165/00002018-199717010-00004.

Sclerotherapy versus sclerotherapy and propranolol in the prevention of rebleeding from oesophageal varices: a randomised study.硬化疗法与硬化疗法联合普萘洛尔预防食管静脉曲张再出血的随机对照研究

Gut. 1996 May;38(5):770-4. doi: 10.1136/gut.38.5.770.

Individual variation in first-pass metabolism.首过代谢的个体差异。

Clin Pharmacokinet. 1993 Oct;25(4):300-28. doi: 10.2165/00003088-199325040-00005.

Disposition kinetics of buspirone in patients with renal or hepatic impairment after administration of single and multiple doses.单次和多次给药后，肾或肝功能损害患者中丁螺环酮的处置动力学。

Eur J Clin Pharmacol. 1994;46(1):41-7. doi: 10.1007/BF00195914.

The use of marker drugs to measure organ function: a theoretical interpretation.

Eur J Clin Pharmacol. 1980 Nov;18(6):511-6. doi: 10.1007/BF00874665.

Roles of hepatic blood flow and enzyme activity in the kinetics of propranolol and sotalol.肝血流量和酶活性在普萘洛尔和索他洛尔动力学中的作用。

Br J Clin Pharmacol. 1980 Apr;9(4):399-405. doi: 10.1111/j.1365-2125.1980.tb01068.x.

本文引用的文献

THE ESTIMATION OF HEPATIC BLOOD FLOW IN MAN.人体肝血流量的估计

J Clin Invest. 1945 Nov;24(6):890-7. doi: 10.1172/JCI101676.

The use of indocyanine green in the measurement of hepatic blood flow and as a test of hepatic function.吲哚菁绿在肝血流测量及肝功能检测中的应用。

Clin Sci. 1961 Aug;21:43-57.

Plasma propranolol levels in adults with observations in four children.成人血浆普萘洛尔水平及对四名儿童的观察结果

Clin Pharmacol Ther. 1970 Jan-Feb;11(1):112-20. doi: 10.1002/cpt1970111112.

Metabolism of niridazole in various species, including man.

Ann N Y Acad Sci. 1969 Oct 6;160(2):544-57. doi: 10.1111/j.1749-6632.1969.tb15874.x.

Gas chromatographic assessment of the reproducibility of phenazone plasma half-life in young healthy volunteers.气相色谱法评估年轻健康志愿者中非那宗血浆半衰期的重现性。

Eur J Clin Pharmacol. 1974 Aug 23;7(5):381-5. doi: 10.1007/BF00558211.

The disposition of propranolol. 3. Decreased half-life and volume of distribution as a result of plasma binding in man, monkey, dog and rat.普萘洛尔的处置。3. 由于人、猴、狗和大鼠体内的血浆结合作用，半衰期和分布容积降低。

J Pharmacol Exp Ther. 1973 Jul;186(1):114-22.

The clearance of antipyrine and indocyanine green in normal subjects and in patients with chronic lever disease.正常受试者及慢性肝病患者中安替比林和吲哚菁绿的清除率

Clin Pharmacol Ther. 1976 Jul;20(1):81-9. doi: 10.1002/cpt197620181.

Effect of portacaval shunt on the disposition of drugs with and without first-pass effect.

J Pharmacol Exp Ther. 1975 Dec;195(3):416-23.

Commentary: a physiological approach to hepatic drug clearance.述评：肝脏药物清除的生理学方法

Clin Pharmacol Ther. 1975 Oct;18(4):377-90. doi: 10.1002/cpt1975184377.

A study of factors influencing drug disposition in chronic liver disease, using the model drug (+)-propranolol.一项使用模型药物（+）-普萘洛尔对慢性肝病中影响药物处置因素的研究。

Br J Clin Pharmacol. 1976 Apr;3(2):243-9. doi: 10.1111/j.1365-2125.1976.tb00599.x.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验